Skip to main content
. 2021 Jan 9;10(1):114. doi: 10.3390/cells10010114

Figure 3.

Figure 3

The plasma levels of indoxyl sulfate and p-cresol sulfate of end-stage kidney disease (ESKD) patients are significantly higher than healthy controls (HC) (panels (A,B,D,E)). The fecal level of a microbial metabolite, indole, tends to be higher in ESKD patients, but the difference did not achieve statistical significance (panel (C)). * p < 0.05.